Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Pazopanib (GW786034) and Cyclophosphamide in Patients With Platinum-resistant Recurrent, Pre-treated Ovarian Cancer

NCT01238770 is registered in ClinicalTrials.gov with Priv.-Doz. Dr. med. Joachim Rom as lead sponsor.

NCT NCT01238770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01238770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Pazopanib (GW786034) and Cyclophosphamide in Patients With Platinum-resistant Recurrent, Pre-treated Ovarian Cancer
Lead sponsor
Priv.-Doz. Dr. med. Joachim Rom
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2010
Completion date
October 31, 2015
Enrollment
10 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial ovarian cancer